CA ATC G04BD02 · updated 2 Nov 2026
Flavoxate shortage in Canada
Is there a Flavoxate shortage in Canada?
Yes. As of 2 Nov 2026, 2 Flavoxate products are reported short in Canada, the first since 19 Mar 2008. No return date has been given. Main reason: other.
Not reported short in any other country we track. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | URISPAS TAB 200MG (100 TABS) | PALADIN LABS INC | 19 Mar 2008 | not given | Other Other (Please describe in comments) |
| CA | APO-FLAVOXATE (100 BTL) | APOTEX INC | 10 Mar 2017 | not given | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.